Literature DB >> 33641273

Critical role of pre-analytical aspects for the measurement of circulating calprotectin in serum or plasma as a biomarker for neutrophil-related inflammation.

Maria Infantino1, Mariangela Manfredi1, Roger Albesa2, Valentina Grossi1, Barbara Lari1, Maurizio Benucci3, Francesca Li Gobbi3, Alessandra Matucci3, Filippo Sarra4, Michael Mahler2.   

Abstract

Entities:  

Keywords:  biomarker; circulating calprotectin; neutrophil-related inflammation; pre-analytical phase

Mesh:

Substances:

Year:  2021        PMID: 33641273     DOI: 10.1515/cclm-2021-0172

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


× No keyword cloud information.
  2 in total

1.  Circulating Calprotectin as a Predictive and Severity Biomarker in Patients with COVID-19.

Authors:  Gary L Norman; Sherwin A Navaz; Yogendra Kanthi; Roger Albesa; Michael Mahler; Jason S Knight; Yu Zuo
Journal:  Diagnostics (Basel)       Date:  2022-05-27

2.  Circulating Calprotectin as a Biomarker of COVID-19 Severity.

Authors:  Michael Mahler; Pier-Luigi Meroni; Maria Infantino; Katherine A Buhler; Marvin J Fritzler
Journal:  Expert Rev Clin Immunol       Date:  2021-04-13       Impact factor: 4.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.